Danish pharmaceutical company Novo Nordisk A/S (NVO) reported Friday that its third-quarter net profit edged up 1 percent to 10.30 billion Danish kroner from last year's 10.19 billion kroner. Earnings per share/ADR grew 3 percent to 4.42 kroner from 4.29 kroner last year.
Operating profit decreased 1 percent from last year to 12.81 billion kroner. The gross margin was 83.3 percent, slightly higher than 83.2 percent last year.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com